Loading provider…
Loading provider…
Emergency Medicine Physician in Little Rock, AR
NPI: 1003925975Primary Practice Location
CHI-ST VINCENT INFIRMARY
2 Saint Vincent Cir, Little Rock, AR
Primary Employer
Shiloh Emergency Group PLLC
commonspirit.org
HQ Phone
Get MD Lee's Phone Numberphone_androidMobile
Get MD Lee's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
AR State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99285Emergency department visit, problem with significant threat to life or function | 190 | 195 |
| 2 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 152 | 161 |
| 3 | 99284Emergency department visit with moderate level of medical decision making | 70 | 77 |
| 4 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 68 | 69 |
Is screening women for intimate partner violence in the emergency department effective?
Authors: Wilbur, Lee, Noel, Nicole, Couri, Gene
Journal: Ann Emerg Med
Publication Date: 2013-07-18
Interprofessional education and collaboration: a call to action for emergency medicine.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Acad Emerg Med
Lead Sponsor: Partner Therapeutics, Inc.
Collaborators: United States Department of Defense
Intervention / Treatment: DRUG: Placebo, DRUG: Sargramostim
Lead Sponsor: Eli Lilly and Company
Collaborators: AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: LY3819253, DRUG: LY3832479, DRUG: LY3853113
Lead Sponsor: Eli Lilly and Company
Collaborators: GlaxoSmithKline, AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd., Vir Biotechnology, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Bebtelovimab, DRUG: Etesevimab, DRUG: Bamlanivimab, DRUG: VIR-7831